Biochip, is a bio-microarray device used for analysis of large-scale genomics, proteomics, and functional genomics. It finds application in clinical research, diagnostics, drug development, toxicology studies, and patient selection for clinical trials.
The U.S. biochip products and services market is estimated to account for US$ 11,151.8 Mn in terms of value by the end of 2027.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/3899
U.S. Biochip Products and Services Market: Drivers
Approval and launch of new products is expected to propel growth of the U.S. biochip products and services market over the forecast period. For instance, in April 2019, AYOXXA Biosystems GmbH launched LUNARISTM Chemokine Kits for exploration of human (Human 11-Plex) and murine (Mouse-12-Plex) chemokine signaling pathways.
U.S. Biochip Products and Services Market: Opportunities
R&D in biochips is expected to offer lucrative growth opportunities for players in the U.S. biochip products and services market. For instance, in May 2020, researchers from Russian Academy of Sciences, Russia, reported development of 3D biochips and optimized analytical procedures that can facilitate further studies towards practical application for hepatitis C virus detection.
U.S. Biochip Products and Services Market: Restraints
Availability of alternative technologies such as mass spectrometry and polymerase chain reaction is expected to limit growth of the market. Technologies such as mass spectrometry and polymerase chain reaction can be used as substitutes to biochips. Mass spectrometry is used to determine and analyze spectra of a number of molecules present in the sample of any material. Polymerase chain reaction is the method of amplification of a single or a few copies of DNA obtained from any source.
Browse Press Release: https://www.coherentmarketinsights.com/press-release/us-biochip-product-and-services-market-3169
The U.S. biochip products and services market was valued at US$ 5,161.8 Mn in 2019 and is forecast to reach a value of US$ 11,151.8 Mn by 2027 at a CAGR of 10.1% between 2020 and 2027. Increasing product approvals and launches during the forecast period.
Microarrays segment held dominant position in the U.S. biochip products and services market in 2019, accounting for 57.5% share in terms of value. Increasing research and development along with increasing prevalence of cancer is expected to drive the market growth.
Integration of biochips with next-generation sequencing. Biochip platforms for single-cell or rare-molecule analyses by next-generation sequencing facilitates convenient preparation of nucleic acids from biological systems.
Increasing development in personalized medicine is expected to aid in growth of the market. Biochips along with next-generation sequencing can be used in drug screening for personalized medicine.
U.S. Biochip Products and Services Market: Competitive Landscape
Major players operating in the U.S. biochip products and services market include, Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, and AYOXXA Biosystems GmbH.
U.S. Biochip Products and Services Market: Key Developments
April 2019: Qurin Diagnostics B.V. and Lionix International B.V. acquired Surfix B.V., a supplier of custom-made nanocoatings
January 2019: AYOXXA Biosystems GmbH signed a research agreement with one of the leading pharmaceutical companies (details were not disclosed) for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3899
Scope of the report
- U.S. Biochip Products and Services Market, By Type:
- Reagents & other Consumables
- U.S. Biochip Products and Services Market, By Application:
- Drug Discovery
- Life Science Research
- IVD Tests
- Company Profiles
- Abbott Laboratories *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Agilent Technologies
- Affymetrix Inc.
- Beckman Coulter, Inc.
- Illumina Incorporated
- Life Technologies Corporation
- Randox Laboratories Ltd.
- Surfix B.V
- AYOXXA Biosystems GmbH
- Abbott Laboratories *
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027